AzTrials
AzTrials

General AnesthesiaMP3NCT05283018

Relationship Between the Depth of Anesthesia and Auditory Evoked Potentials (P3a)

An observational study of General Anesthesia, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The interest of perioperative cerebral monitoring and in particular electroencephalography (EEG) to reduce neurological and cognitive damage in surgery has been the subject of abundant research and corresponds to a crucial issue. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
General Anesthesia
What is being tested?
Electroencephalogram recording, Auditory stimulation and Transcranial Doppler
Type of treatment
Medical device
How many people
0 participants
Where
1 siteFrance
Study dates
Dec 2023to Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients eligible for an outpatient or scheduled surgery procedure under general anesthesia

Who may be able to join

  • Major patients (≥ 18 years old)
  • Eligible for an outpatient or scheduled surgery procedure under general anesthesia
  • Patient who expressed his non-opposition to participation in this research

Who cannot join

  • Patient under the age of 18
  • Pre-existing auditory sensorineural impairment
  • Severe pre-existing cognitive impairment (preoperative mini-mental state examination MMSE < 24)
  • Patient opposed to participation in the protocol
  • Pregnant woman
  • Patient under judicial protection measure
  • Patient without affiliation to a social security scheme
  • Patient benefiting from the State medical assistance (AME) programme

Trial locations and contacts

1 site in 1 country.

France1 site
  • AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care

    Paris, 75010

Other trials in France

About this study

Official title: Continuous Monitoring of the P3a Response During General Anesthesia Using the Rough Auditory Stimuli Coupled to the Analysis of Frontal EEG Signal

The interest of perioperative cerebral monitoring and in particular electroencephalography (EEG) to reduce neurological and cognitive damage in surgery has been the subject of abundant research and corresponds to a crucial issue. There is increasing evidence to suggest that inadequate (overdosed) anesthesia for patient characteristics and intraoperative hemodynamic instability is associated with an increased risk of complications including postoperative cognitive dysfunction and postoperative mortality.

However, these devices have many limitations in use, in particular their consideration of the muscle component of the electrical signal collected.There are other identifiable EEG signals that can be used to assess the depth of anesthesia, in particular auditory evoked potentials (AEPs).

Read more

The so-called rough sound waves correspond to a formulation composed of the rapid repetition of acoustic segments, at a frequency of 30 to 150 Hz.This frequency (whether sound or light) induces a temporal activation that captures attention and provokes unpleasant sensations and avoidance strategies when perceived by a subject.

This project aims at overcoming the interaction of the muscular electrical signal by evaluating the electrophysiological response (auditory evoked potentials) to particular sound stimuli, called "rough", thus underpinning the understanding of the mechanisms of neurosensory integration and attention during a state of loss of consciousness or altered consciousness.

The hypothesis proposed for this study is the following: the P3a wave (positive wave collected on the EEG during auditory evoked potentials) is altered during general anesthesia, in frequency and amplitude, and thus is indicative of the depth of the anesthetic state.

Read the detailed description

Monitoring the depth of anesthesia remains a challenge for anesthesiologists. There is increasing evidence to suggest that inadequate (overdosed) anesthesia for patient characteristics and intraoperative hemodynamic instability is associated with an increased risk of postoperative complications and mortality.

Monitoring of cortical electroencephalogram (EEG) analysis has developed over time to address three daily issues:

  • Prevention of hypnotic overdose
  • The prevention of hypnotic underdosing, exposing to an increased risk of explicit perianesthetic memory
  • The discussed relationship between a poor electroencephalographic trace, associated with a lowered blood pressure and a low dose of hypnotics used, and mortality at a distance from the anesthetic act (triple low concept).

However, these devices have many limitations in use, in particular their consideration of the muscle component of the electrical signal collected.

However, there are other identifiable EEG signals that can be used to assess the depth of anesthesia, in particular auditory evoked potentials.

The technique currently used to monitor the depth of anesthesia is the measurement of the bispectral index. However, this technique has its limits of use linked to the possible modifications of their interpretability by certain pharmacological agents (ketamine, high dose morphinics, Neuromuscular blockers, beta-blockers and ephedrine), by the electric scalpel and by persistent muscle contractions. In addition, the delay in analysis (about 30 seconds) may delay the interpretation of the result and the resulting therapeutic interventions.

The study of auditory evoked potentials seems to provide an alternative. Indeed, it has been shown in several studies that the P300 wave (or P3), a positive wave appearing at 300ms of stimulation) is partially inhibited by anesthesia and that its amplitude could be correlated to its depth.

These P300 waves are not affected by the different factors that can disturb the analysis of the bispectral index.

The rapid repetition of a sound or light signal produces a marked activation of certain neuronal chains in the temporal areas, particularly involved in the field of attention. This can induce undesired sensations and promote avoidance and distancing from the source. The repetition of a signal at a frequency of 40 to 80 Hz is perceived as particularly provoking.

Rough sounds synchronize auditory cortical regions as well as some frontal and limbic cortical regions and other subcortical regions.

This also suggests that the negative perception of rough sounds would be related to their ability to take control of neural networks usually involved in negative emotions and pain integration

The hypothesis proposed for this study is the following: the P3a wave (positive wave collected on the EEG during auditory evoked potentials) is altered during general anesthesia, in frequency and amplitude, and thus is indicative of the depth of the anesthetic state

Patients over 18 years old are eligible to participate in this protocol. During the anaesthesia consultation, they will be given a letter of information on the objectives and progress of the study. Their non-opposition to participating in this study will be collected at the latest during the pre-anaesthetic visit, the day before the operation, after a period of reflection. The patient will be offered to listen to the sounds used during this visit.

The protocol will start on the day of the operation. The procedures will be performed under general anesthesia. The protocol does not interact with the care procedure.

On the day of the procedure, a headset that is not a medical device is placed on the patient's ears. The P3a wave is collected using the EEG headband used in the operating room (Bispectral Index-BIS or PSI) to monitor the depth of anesthesia. The detection of this wave involves a post-processing phase of the signal and does not influence the anesthetist in charge of the patient.

The remaining non-invasive monitoring of brain function includes frontal EEG (Bispectral Index, BIS), bilateral transcranial Doppler, and a NIRS sensor used routinely for this type of procedure.

No invasive devices were used in addition to those required for anesthesia. All the monitoring instruments described above, except the one studied, are already used routinely in the department. The duration of anesthesia is not prolonged for the study.

The sound signals are emitted during the awake phase, the anesthetic induction and the awakening phase.

No additional examination will be performed. The anesthetic strategy is decided by the anesthesiologist in charge of the procedure.

The physician in charge of the study collecting the data does not intervene at any time in the management of the patient. The measures cannot influence the prescribing physician since at this stage the data are not yet analyzed and available.

Pilot study: No calculation of the number of subjects required due to the lack of comparable published data.

Effect size: In a reference article describing the effect of propofol during general anesthesia on P3 wave amplitude and latency, the observed variations in P3 wave latency were of the order of 50%.

Moreover, the proportion of patients for whom a sufficient depth of anesthesia is not reached with discordance between the bispectral index and the clinic is 20%. Assuming in the first group a latency μ_1=50% with a standard deviation of 10% and in the second group μ_1= 30% with a standard deviation of 20%. The sample size required to reject the H0 hypothesis: μ_1=μ_2 with a significance level of 0.05 and a power of 80% (1 - Type II error) via a Wilcoxon-Mann-Whitney test is N= 43 patients.

A target of 50 patients seems relevant.

The variations of P3 during induction and wake-up will be tested using a Student-t test after testing the normality of the distribution. The correlation between P3 variations and variations of EEG features (Burst suppression, SEF95) during induction and wake-up will be done using Pearson test. A full multivariate analysis will also be performed. All statistical analyses will be performed using R statistical software (The 'R' Foundation for Statistical Computing, Vienna, Austria). Results will be expressed as means (± standard deviation). A p-value of less than 0.05 is considered significant.

Being tested
Electroencephalogram recording, Auditory stimulation, Transcranial Doppler, Near-infrared spectroscopy
Keywords
Auditory Evoked Potentials, Electroencephalography Phase Synchronization, P3 Event-Related Potentials, Depth of anesthesia, Acoustic Stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electroencephalogram recordingDevice

    Brain function monitoring using a Sedline® module (Masimo corporation) to evaluate the state of the brain under anesthesia

  • Auditory stimulationOther

    Monotonous sounds are sent via binaural headphones: a standard item and a distractor item (rough sound). Each stimulus lasts about 300 ms and they are separated by 1.5 to 2 seconds between them; the deviant sound/standard sound ratio is fixed between 1/5 and 1/6.

  • Transcranial DopplerDevice

    Measurement of cerebral blood flow velocity (CFV) with use of Transcranial Doppler ultrasonography. For all patients, CFV (unit cm/s) will be collected over four distinct periods: 1/ baseline or during pre-oxygenation at inspired oxygen fraction (FiO2) of 21% in awake patients; 2/ during anesthetic induction; 3 /deep sleep; 4/ recovery period.

  • Near-infrared spectroscopyDevice

    Continuous measurement of cerebral oxygen saturation (SO2) with Near-infrared spectroscopy (NIRS).

    For all patients, SO2 (%) will be collected over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3 /deep sleep; 4/ recovery period.

Study groups in NCT05283018
Study groupRoleWhat they receive
Surgery under general anesthesiaPatients undergoing urgent or scheduled surgery at Lariboisière Hospital
Receives: Device: Electroencephalogram recording; Other: Auditory stimulation; Device: Transcranial Doppler; Device: Near-infrared spectroscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of the P3a subcomponent of the P300

    EEG monitoring of the P3a wave obtained by emission of rough sound signals: duration of P3a (ms) wave onset periods over four distinct periods: 1/baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  2. P3a amplitude

    EEG monitoring of the P3a wave obtained by emission of rough sound signals: P3a amplitude (A in µV) over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  3. P3a frequency

    EEG monitoring of the P3a wave obtained by emission of rough sound signals: P3a wave frequency (FP3 in Hz) over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  4. Depth of anesthesia

    Depth of anesthesia measured by bispectral index (BIS, MASIMO, %) over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

Secondary outcomes (5)
  1. Mean arterial blood pressure

    For all patients, the mean arterial pressure (mmHg) will be collected continuously, over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  2. Cerebral blood flow velocity (CFV)

    For all patients, CFV (unit cm/s) will be collected continuously, using Transcranial Doppler, over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  3. Burst Suppression (BS)

    For all patients, continuous measurement of BS duration (%) over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  4. Spectral Edge Frequency (SEF95)

    For all patients, continuous measurement of SEF95 on intraoperative EEG - BIS in %, over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  5. Cerebral oxygen saturation

    For all patients, the cerebral oxygen saturation (SO2; %) will be collected continuously using NIRS over four distinct periods: 1/ baseline or during pre-oxygenation at FiO2 of 21% in awake patients; 2/ during anesthetic induction; 3/ deep sleep; 4/ recovery period.

    Measured: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2022
  2. Study startDec 2023 (estimated)
  3. Primary completionDec 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Why it stopped: The reasons are technical. The equiment is not compatible with the sampling rate required to obtain the desired EEG signal.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05283018
Sponsor's protocol ID
APHP211287
Other IDs
2021-A02322-39
Acronym
MP3
Status last verified
Aug 2026
First submitted
7 Mar 2022
Last updated
19 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of General Anesthesia, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of the P3a subcomponent of the P300 (time frame: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in